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Abstract
Protein cysteines can form transient disulfides with glutathione (GSH), resulting in the pro-
duction of glutathionylated proteins, and this process is regarded as a mechanism by which
the redox state of the cell can regulate protein function. Most studies on redox regulation of
immunity have focused on intracellular proteins. In this study we have used redox proteo-
mics to identify those proteins released in glutathionylated form by macrophages stimulated
with lipopolysaccharide (LPS) after pre-loading the cells with biotinylated GSH. Of the sev-
eral proteins identified in the redox secretome, we have selected a number for validation.
Proteomic analysis indicated that LPS stimulated the release of peroxiredoxin (PRDX) 1,
PRDX2, vimentin (VIM), profilin1 (PFN1) and thioredoxin 1 (TXN1). For PRDX1 and TXN1,
we were able to confirm that the released protein is glutathionylated. PRDX1, PRDX2 and
TXN1 were also released by the human pulmonary epithelial cell line, A549, infected with in-
fluenza virus. The release of the proteins identified was inhibited by the anti-inflammatory
glucocorticoid, dexamethasone (DEX), which also inhibited tumor necrosis factor (TNF)-α
release, and by thiol antioxidants (N-butanoyl GSH derivative, GSH-C4, and N-acetylcys-
teine (NAC), which did not affect TNF-α production. The proteins identified could be useful
as biomarkers of oxidative stress associated with inflammation, and further studies will be
required to investigate if the extracellular forms of these proteins has immunoregulatory
functions.
PLOS ONE | DOI:10.1371/journal.pone.0127086 May 18, 2015 1 / 21
OPEN ACCESS
Citation: Checconi P, Salzano S, Bowler L, Mullen L,
Mengozzi M, Hanschmann E-M, et al. (2015) Redox
Proteomics of the Inflammatory Secretome Identifies
a Common Set of Redoxins and Other
Glutathionylated Proteins Released in Inflammation,
Influenza Virus Infection and Oxidative Stress. PLoS
ONE 10(5): e0127086. doi:10.1371/journal.
pone.0127086
Academic Editor: Juan Sastre, University of
Valencia, SPAIN
Received: November 11, 2014
Accepted: April 11, 2015
Published: May 18, 2015
Copyright: © 2015 Checconi et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by the RM
Phillips Charitable Trust (to PG), European
Development Fund, Interreg Project Peptide
Research Network of Excellence, Perene (to PG), the
EU COSTaction EU-ROS (to PG), the Deutsche
Forschungsgemeinschaft (DFG SFB593-N01 to
CHL), the von Behring-Röntgen Foundation (to CHL),
the Italian Ministry of Instruction, University and
INTRODUCTION
Infection, autoimmunity, tissue stress and tissue injury can all induce inflammation [1]. Patho-
gens, through specific pathogen-associated molecular patterns such as endotoxin, viral proteins
or nucleic acids, induce expression and release of inflammatory cytokines through activation of
various pattern recognition receptors including Toll-like receptors [2, 3]. They also induce the
release of endogenous proteins that are normally present intracellularly such as high-mobility
group box-1 (HMGB1) [4]. These proteins are often classified as damage-associated molecular
patterns because, being normally present in the cell, are obviously also released as a result of ne-
crosis, independent of the mechanism that triggered cell death [5].
Oxidative stress is caused by an imbalance between the production of reactive oxygen spe-
cies (ROS) and the ROS-detoxifying capacity of the cells [6]. ROS are thought to play a role in
triggering or sustaining the inflammatory response, and may be particularly important in path-
ological conditions such as ischemia/reperfusion injury, typically associated with high oxida-
tive stress [7], but also in infectious diseases such as influenza [8–10] or during HIV infection
[11, 12]. Pioneering studies by Bauerle have shown that nuclear factor-kappa B is one of the
redox-sensitive targets in inflammation, as shown by its activation by ROS and its inhibition by
thiol antioxidants such as glutathione (GSH) [13]. More recently, other signalling molecules in
the inflammatory cascade, including a member of the NLR family, the pyrin-like protein,
NALP3 (a signal transducer and activator of transcription), have been shown to be redox regu-
lated [14, 15]. On the other hand, while a number of studies reported inhibition of cytokine
production by thiol antioxidants, possibly through the above-mentioned inhibition of nuclear
factor-kappa B, it is unclear whether ROS alone can directly trigger inflammatory cytokines
and to what extent. It has been reported that low levels of hydrogen peroxide induces produc-
tion of IL-1, TNF, and chemokines in mouse peritoneal macrophages [16], and we previously
reported that a ROS-generating toxicant, paraquat, potentiates induction of IL-1, IL-8 and
TNF by LPS but does not induce these cytokines in the absence of LPS [17, 18]. In contrast,
hydrogen peroxide, even at non-toxic concentrations, had a marked effect on the release of
HMGB1, indicating that damage-associated molecular patterns might be an important media-
tor of oxidative stress-associated inflammation [19].
Recently, the focus has shifted from the concept of oxidative damage to that of redox regula-
tion. According to the latter concept, there are a number of metabolic pathways that are regu-
lated by the redox state of the cell, which is defined as the reduced/oxidized ratio for some
metabolites, particularly NADH/NAD, NADPH/NADP, GSH/GSSG [20]. One mechanism by
which the redox state of the cell affects the function of proteins, for instance, enzymes, tran-
scription factors and transporters, is via oxidoreduction of redox-sensitive cysteines in the pro-
tein sequence. This can occur in a number of ways: reversible formation of disulfide bonds
within the same protein or between distinct proteins; formation of mixed disulfides with small-
molecular weight thiols including GSH (protein glutathionylation), or free cysteine (protein
cysteinylation) [21]; or via other forms of reversible oxidation such as formation of S-nitro-
sothiols or other oxidized species, for instance sulfenic or sulfinic acids [22].
We previously developed “redox proteomics” techniques to identify intracellular proteins
whose cysteines are redox-sensitive, and successfully applied it to the identification of cysteines
undergoing glutathionylation in lymphocytes [23], or membrane proteins whose exofacial
thiols are potential targets of redox regulation [24, 25]. Recently, we applied this technique to
identify those proteins that are released in the glutathionylated form by LPS-stimulated macro-
phages, and identified PRDX2 as a potential inflammatory mediator [26].
We report here a list of other proteins identified as released in the glutathionylated form fol-
lowing LPS-stimulation of RAW264.7 mouse macrophages, a cell line which has been used for
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the identification of inflammatory mediators such as TNF [27] and HMGB1 [4]. The strategy
employed was based on the use of a biotinylated GSH ethyl ester, (BioGEE) to label the intra-
cellular GSH pool [28]. Glutathionylated proteins released in the LPS-stimulated supernatant
would then carry a biotin tag and could be purified by binding to streptavidin-agarose followed
by elution, tryptic digestion and identification by mass spectrometry. Release of specific pro-
teins, augmentation of release by LPS and glutathionylation of the secreted protein were then
confirmed using more specific techniques. [29]We also studied the effect of infection with in-
fluenza virus, known to induce a decrease of GSH in the cell [30, 31]. Finally we tested the effect
of a classical anti-inflammatory agent, dexamethasone phosphate (DEX), and two thiol antioxi-
dants, the GSH synthesis precursor N-acetyl-L-cysteine (NAC) [32] and the cell-permeable
N-butanoyl GSH derivative, GSH-C4 [33, 34] on LPS-stimulated release of the proteins
identified.
The results indicate that the LPS-induced release of a number of the proteins investigated
can be pharmacologically modulated by thiol antioxidants and anti-inflammatory drugs.
RESULTS
Identification of redoxins and other glutathionylated proteins released in
response to LPS stimulation
The protocol for the identification of glutathionylated proteins released by LPS-stimulated
RAW264.7 mouse macrophages has been described before [26]. Briefly, supernatants from
cells pre-loaded or not with BioGEE and then stimulated with LPS were run on a non-reducing
SDS-PAGE followed by Western blot with streptavidin-peroxidase (S1 Fig). A number of pro-
teins were detected in the releasate, while supernatants from cells without BioGEE treatment
gave no visible bands. When samples were reduced with DTT before electrophoresis, fewer
bands were stained by streptavidin-peroxidase, indicating that in most cases incorporation of
biotin was due to a mixed disulfide formation, as it would be in the case of glutathionylation.
Similar results were obtained when cells were pre-loaded with BioGEE for 1 h, then BioGEE
was removed and the released biotinylated proteins analysed by Western blot (S1B Fig).
To identify BioGEE-labelled proteins we used two different strategies, which essentially dif-
fered in the use of prior electrophoretic separation. In the first experiment, proteins in the su-
pernatant from BioGEE-preloaded, LPS-stimulated cells were affinity-purified on streptavidin
beads, and bound proteins were identified following tryptic digestion in situ by LC-MS/MS. A
parallel sample prepared without BioGEE was processed in the same way and proteins were
also identified. The full list of proteins is available as Supporting Information, S1 Table. In the
second experiment, the supernatant from BioGEE-preloaded, LPS-stimulated cells was incu-
bated with streptavidin agarose, eluted with DTT for 30 min at room temperature and then
again with DTT for 10 min at 100°C. The eluate was then fractionated by SDS-PAGE under re-
ducing conditions and proteins visualised by staining with Coomassie Blue. The three visible
bands (S2 Fig) were excised and subjected to tryptic digestion and MS analysis. The proteins
identified are listed in the Supporting information, S2 Table.
Table 1 lists the proteins identified in the first experiment from BioGEE-preloaded, LPS-
stimulated cells. The columns on the left indicate which proteins were unique to BioGEE-pre-
treated cells, as detection in the absence of BioGEE may indicate non-specific binding of the
protein to the beads. The last column of Table 1 indicates those proteins that were also identi-
fied in excised gel slices from the SDS-PAGE separation. Although this might be a confirma-
tion of the identification, one should bear in mind that only peptides from three bands were
'sequenced', thus limiting the identification to those proteins that are in a limited molecular
weight range.
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Table 1. Proteins identified from BioGEE-treated samples.
Protein name Accession number Unique Gel
50 kDa protein IPI00311569, IPI00462482
p
78 kDa glucose-regulated protein IPI00319992
p
Actin, cytoplasmic 1 IPI00110850
Alpha-enolase IPI00462072
Bifunctional aminoacyl-tRNA synthetase IPI00339916, IPI00673707
p
Cathepsin B IPI00113517
p
Elongation factor 1-alpha 1 IPI00307837
Elongation factor 1-gamma IPI00318841
Elongation factor 2 IPI00466069
p
Envelope polyprotein IPI00420148, IPI00626977, IPI00754463, IPI00845606, IPI00845754, IPI00845857,
IPI00923031
p
Exportin-1 IPI00395038
p
Fatty acid synthase IPI00113223
p
Glucose-6-phosphate 1-dehydrogenase X IPI00228385, IPI00857114
p
H-2 class I histocompatibility antigen, L-D alpha
chain
IPI00109996
p
Heat shock 70 kDa protein 4 IPI00331556
p
Heat shock cognate 71 kDa protein IPI00323357, IPI00886297
p
Heat shock protein HSP 90-alpha IPI00330804
p
Hypoxanthine-guanine phosphoribosyltransferase IPI00284806
p
Isoform 1 of Filamin-A IPI00131138, IPI00664643, IPI00875567, IPI00921658
p
Isoform 1 of Interleukin-1 receptor antagonist
protein
IPI00136858, IPI00466271, IPI00751888, IPI00752375
Isoform 2 of Tropomyosin alpha-3 chain IPI00230044, IPI00459570
p
Isoform C of Lamin-A/C IPI00400300, IPI00620256
Isoform M2 of Pyruvate kinase isozymes M1/M2 IPI00407130, IPI00845840
Keratin, type II cytoskeletal 1 IPI00625729
L-lactate dehydrogenase A chain IPI00319994, IPI00751369
p
Multifunctional protein ADE2 IPI00322096, IPI00624863
p
Nucleolin IPI00317794
p
Peptidyl-prolyl cis-trans isomerase B IPI00135686
Peroxiredoxin-1 IPI00121788, IPI00648105, IPI00648615
Peroxiredoxin-2 IPI00117910
p
Phosphoglycerate kinase 1 IPI00555069
Plastin-2 IPI00118892
Profilin-1 IPI00224740, IPI00650039
p
Protein disulfide-isomerase A3 IPI00230108
Putative uncharacterized protein IPI00309520, IPI00877231
Putative uncharacterized protein IPI00229080
Putative uncharacterized protein IPI00126248, IPI00762047
similar to Protein disulfide isomerase associated
6
IPI00854971
Sulfated glycoprotein 1 IPI00321190, IPI00928070, IPI00928204, IPI00928284, IPI00928320, IPI00928581
p
T-complex protein 1 subunit epsilon IPI00116279
p
Transgelin-2 IPI00125778
Transketolase IPI00137409
p p
Triosephosphate isomerase IPI00467833
Tubulin alpha-1B chain IPI00117348
(Continued)
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We decided to further investigate peroxiredoxin (PRDX) 1, PRDX2, vimentin (VIM) and
profilin1 (PFN1), all identified in the first experiment, as well as thioredoxin 1 (TXN1), identi-
fied only in the second experiment. PRDX2 and TXN1 have already been reported as secreted
by LPS-stimulated macrophages in our previous study [26]. We decided to investigate PFN1
because, although in this study it was also identified in the absence of BioGEE treatment, it had
already been identified as susceptible to glutathionylation in a previous redox proteomics
study, although in the cytosol [23]. Likewise, PRDX1 was selected for further study, even
though it was also identified in the absence of BioGEE treatment because of its similarity to
PRDX2. Because the mass spectrometry method used in this study for protein identification is
not quantitative, and we only analyzed supernatants from LPS-stimulated cells, identification
of a protein in our redox proteomics experiment does not necessarily imply the protein is re-
leased in response to LPS. Furthermore, proteins identified in this way may also be contami-
nants released from dead cells. Therefore, we first sought to confirm the release of these
proteins by Western blotting using specific antibodies. Fig 1A shows Western blot analysis for
the different proteins in supernatants and cell lysates 24 h after stimulation with or without
100 ng/ml of LPS. In this experiment, SDS-PAGE was run under non-reducing conditions.
PRDX2 is present intracellularly as both a monomer and a disulphide-linked dimer, and LPS
induces release of the dimer but not of the monomer, as previously reported [26]; we report
here the same pattern of secretion for PRDX1.
We were also able to demonstrate that TXN1, VIM and PFN1 are constitutively present in
the cell and released in response to LPS. Unlike PRDXs, these proteins ran only as a major
band on the SDS-PAGE gels, migrating near their predicted molecular weight. Although in
non-reducing conditions it is impossible to determine the accurate molecular weight as protein
migration is also affected by other factors, such as 3D conformation and the presence of disul-
fide bonds, it was clear that these proteins were not released as dimers. The results with VIM
are less clear. The molecular weight of mouse VIM is 53 kDa but in our Western blots the main
band is at 42–44 kDa, both in supernatants and in the cell lysate (Fig 1A). We thus also ana-
lysed secreted TXN1, VIM and PFN1 in reducing conditions. As shown in Fig 1B, TXN1 and
PFN1 migrate to the expected molecular weight (12 kDa and 15 kDa, respectively), but once
again VIM showed a lower molecular weight than expected, and for this reason it was not in-
vestigated further in the present study.
We wondered whether the fact that secreted PRDXs are only found as dimers is not simply
due to their oxidization after secretion in the oxidizing extracellular milieu that might also con-
tain hydrogen peroxide released by the cells. However, when human recombinant, monomeric,
PRDX2 was added to cultured cells, we could still detect the monomer after 24 h culture (S3
Fig) indicating that dimerization probably occurs before or during the process of release, rather
than once it is released. This is in agreement with our previous findings in HEK293 cells [35].
Given the novelty of the findings, we wanted to exclude beyond any doubt the possibility
that the release of the proteins investigated was not due to leakage associated with a small
amount of cell lysis possibly induced by LPS. As a first approach, we measured cell viability
using two different assays.
Table 1. (Continued)
Protein name Accession number Unique Gel
Tubulin beta-5 chain IPI00117352
Vimentin IPI00227299
p
doi:10.1371/journal.pone.0127086.t001
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Using CellTiter Blue, viability of cells treated 24 h with 100 ng/ml LPS was 99.6 ± 1.9% of
control cells (n = 4). As shown in S4 Fig, the assay used would have detected a 5% decrease in
the number of live cells. Because the CellTiter Blue assay is based on an oxidoreductive reac-
tion, we wanted to confirm these measurements with a different assay. We used the CellTiter
Glo assay that is based on the measure of the ATP content of the cells. Also with this assay, via-
bility of cells treated 24 h with 100 ng/ml LPS was 99.6 ± 7.0% of control cells (n = 10). Further-
more, we measured TNF production in the 24-h supernatants, and LPS induced high TNF
levels (control, 0.7 ± 0.1 ng/ml; LPS, 99.2 ± 1.3 ng/ml; n = 3).
Finally, we designed an experiment to calculate the percentage of cell lysis that would be re-
quired to fully explain the quantity of proteins detected in the supernatant. For this purpose we
Fig 1. LPS induces release of PRDX1, PRDX2, TXN1, VIM and PFN1.Western blot analysis following non-reducing (A) or reducing (B) SDS-PAGE (10%
acrylamide for VIM, 12% for PRDXs, 15% for TXN1 and PFN1) of RAW264.7 supernatants cultured with and without 100 ng/ml LPS for 24 h. Supernatants
were blocked with 40 mMNEM immediately after collection, to prevent thiol-disulfide exchange. Cell lysates were also analyzed after blocking with NEM.
doi:10.1371/journal.pone.0127086.g001
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treated cells in 1 ml of culture medium for 24 h with and without LPS and collected the super-
natant. In parallel wells, the same number of cells was lysed in the same volume (1 ml) of SDS
sample buffer. We then loaded the same volume (25 μl) of supernatant or of cell lysate at differ-
ent dilutions corresponding to different percentages of the lysate (25 μl of undiluted lysate
would represent a 100% cell lysis, a 1:2.5 dilution would correspond to a 40% cell lysis and so
on). AWestern blot for PRDX1 was then performed. As shown in Fig 2, more then 40% of cell
lysis would be necessary to explain the amount of PRDX1 detected in LPS-stimulated superna-
tants. The membrane was then stripped and reprobed with anti-beta actin, as a loading control
for cell lysate. Increasing percentages of cell lysates correlate with increasing amounts of actin,
and this was not detectable in the supernatants.
Proteins identified in supernatants from BioGEE-preloaded, LPS-treated RAW264 macro-
phages purified on streptavidin-agarose. Full set of data is reported in S1 Table. Ticks indicate
the proteins that are unique to the BioGEE samples as opposed to the untreated control (S1
Table), or (last column) those that were also identified in bands from electrophoretic separa-
tion and listed in S2 Table.
The full set of data, with the list of proteins identified in samples with and without BioGEE
are available in the Supporting information.
Confirmation of glutathionylation of secreted redoxins by Western blot
analysis
The experimental design used should, in theory, specifically identify glutathionylated proteins.
However, it is possible that some proteins might bind to streptavidin beads non-specifically,
Fig 2. Cell lysis cannot account for LPS-induced release of PRDX1.Western blot analysis following non-reducing SDS-PAGE (12% acrylamide) of
RAW264.7 supernatants obtained from cells cultured with or without 100 ng/ml LPS for 24 h (1 x106 cells in 6 well plates in 1ml of OPTI-MEM) and of different
percentages of cell lysate obtained from the same number of cells, cultured without LPS, resuspended in 1ml sample buffer (to mimic a supernatant
containing the maximum amount of PRDX1 that would be released if 5, 10, 20, 40 or 100% of the cells were necrotic). Top, Western blot for PRDX1. Bottom,
the same membrane was stripped and reprobed with anti-actin as a reference intracellular protein. Arrows indicate the position of Actin and PRDX1. Please
note that some residual PRDX1 was still detected after stripping (bottom gels).
doi:10.1371/journal.pone.0127086.g002
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i.e. even in the absence of glutathionylation, and in fact some proteins were identified in the
first experiment even in the absence of BioGEE. Thus, we tried to confirm the glutathionylation
by a different approach. We have reported previously that PRDX2 released by LPS-stimulated
RAW264.7 macrophages is glutathionylated [26]. In this study, we performed an immunopre-
cipitation for PRDX1 or TXN1, followed by Western blotting with streptavidin-peroxidase.
As shown in Fig 3A, anti-PRDX1-immunoprecipitated samples, when blotted with strepta-
vidin-peroxidase identified a band compatible with the PRDX1 dimer. Stripping the membrane
and re-probing with anti-PRDX1 confirmed the identity of this band as the PRDX1 dimer.
When samples had been previously reduced with DTT, the band visualized with streptavidin
disappeared, indicating the presence of a mixed disulphide with BioGEE. Of note, when the
DTT-reduced sample was stained with anti-PRDX1 antibody, only the monomeric form of the
protein was visible.
We could also confirm, using the same experimental approach, the glutathionylation of se-
creted TXN1 (Fig 3B). Streptavidin-peroxidase revealed only one band, of a molecular weight
compatible with TXN1 that was not present in samples reduced with DTT. Immunostaining of
the same membrane with anti-TXN1 antibody confirmed the identity of the band as TXN1.
Release of redoxins from influenza virus-infected cells
We investigated whether influenza virus infection caused release of redoxins. For this purpose
we infected A549 human lung epithelial cells with Influenza PR8 virus (4 multiplicity of infec-
tion units for 24 h, conditions in which we could detect virus production, 6 ± 2 hemagglutinin
units), and analyzed supernatants and cell lysates by Western blot following electrophoresis
under non-reducing conditions.
As shown in Fig 4A, infected cells released higher levels of PRDX1 and PRDX2 compared to
control cells. In these experiments, control cells had a considerable basal release of PRDX1 and
PRDX2 when compared with RAW264.7 macrophages, although this may be due to the differ-
ent cell type. Also in this case, PRDX1 and PRDX2 were released only in the dimeric form. In-
terestingly, the PRDX2 dimer runs as a doublet in influenza-infected cells, but as a single band
in non-infected controls.
Fig 3. Proteins released in glutathionylated form. Proteins in the NEM-blocked supernatants from BioGEE-pretreated, LPS-stimulated cells were
immunoprecipitated with anti-PRDX1 (A) or anti-TXN1 (B). Immunoprecipitated proteins were run under non-reducing (two lanes on the left) or reducing
conditions (the two lanes with DTT, on the right). Proteins were then visualized byWestern blot with streptavidin peroxidase. The same blot was stripped and
reprobed with anti-PRDX1 or anti-TXN1 antibody to locate the proteins (left, in both A and B). m, monomer; d, dimer.
doi:10.1371/journal.pone.0127086.g003
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Release of TXN1 was also markedly induced by viral infection while, unlike PRDX1 and
PRDX2, little or no TXN1 was released in non-infected cells. This was associated with a visible
decrease in the intracellular TXN1 levels. Influenza-infected cells also showed a marked in-
crease in IL-6 production (Fig 4B) as reported previously [36].
We also wondered whether redoxins could be secreted by infected cells present in the viral
particles. For this purpose, we immunoprecipitated the viral particles with an anti-influenza
antibody and analyzed the supernatant and the immunoprecipitate by Western blot. As shown
in Fig 5, PRDX1 was only detected in the supernatant but not in the immunoprecipitate. As a
control, we also measured the influenza hemagglutinin (HA) that, as expected, was present in
the immunoprecipitate from infected cells (but not in mock infected) to indicate that immuno-
precipitation was effective. From these data one can conclude that PRDX1 is not released asso-
ciated with the virions.
Inhibition of LPS-induced release of redoxins and PFN1 by
dexamethasone and thiol antioxidants
We investigated the effect of DEX and thiol antioxidants (GSH-C4 and NAC) on the secretion
of PRDX2 and other redoxins. The effect of 10 μMDEX on the release of these proteins is
shown in Fig 6A. It can be seen that in both experiments DEX inhibited, although to a different
extent, the release of most of the proteins studied. We also measured TNF-α levels, as a refer-
ence LPS-induced cytokine, in the same supernatants. The results of the ELISA shown in Fig
6B indicate that, under these experimental conditions, DEX lowered TNF-α production by
50%.
We then tested NAC, added at the concentration of 10 mM, together with 1–100 ng/ml
LPS. PRDX2 was analysed by Western blot but the results of this preliminary experiment were
difficult to interpret. In fact, while LPS induced a dose-dependent release of PRDX2 dimer,
only the monomer was detected when NAC was present (S5 Fig). It is likely that NAC acts as a
reducing agent, reducing the PRDX2 dimer after its release. We thus studied the effect of
Fig 4. Influenza virus induces release of redoxins.Western blot analysis following non-reducing (12% for PRDXs and 15% for TXN1) SDS-PAGE of A549
supernatants and cell lysates. A549 cells were infected with PR8 virus (+) or mock-infected (-) for 24 h as described in the Methods. Cell lysates were also
analyzed after blocking with 40 mMNEM. B. IL-6 levels as measured by ELISA. Data are mean ± SE from three independent samples. *P<0.01 vs. non-
infected cells by Student’s t-test.
doi:10.1371/journal.pone.0127086.g004
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GSH-C4 and NAC using a 2-h pretreatment, to allow entry into cells, then washing the cells to
eliminate residual thiols from the supernatants, before the addition of LPS for 24 h. As shown
in Fig 7A, GSH-C4 significantly inhibited the release of PRDX1 and PRDX2, while NAC was
less effective. Under these experimental conditions, production of TNF-α was not affected
(Fig 7B).
DISCUSSION
Using redox proteomics to identify glutathionylated proteins in the secretome of LPS-stimulate
macrophages, we identified a number of proteins, some of which have not been previously de-
scribed, released in response to LPS or to influenza virus infection. Our proteomics identifica-
tion was validated using specific antibodies to these proteins by Western blot, demonstrating
that they are in fact released by macrophages in response to LPS, or by epithelial cells in re-
sponse to influenza virus infection.
Previous studies on identification of glutathionylated proteins have focused on the analysis
of soluble proteins located in the cell lysates, predominantly cytoplasmic proteins [37, 38]. In
fact, it is often thought that cytosolic proteins are rich in free thiol groups and have few struc-
tural disulfides because of the highly reducing environment in the cytoplasm, while extracellu-
lar proteins have fewer free thiols and are rich in disulfide bonds because the extracellular
environment is an oxidizing one [39, 40]. Free thiols of cytosolic protein can form reversible di-
sulfides [23, 41, 42], including those with GSH. Secreted proteins with a reactive cysteine, such
as serum albumin, can be found in the serum in the cysteinylated form, rather than glutathio-
nylated [43], because extracellularly the cysteine/cystine couple is present at higher concentra-
tions than that of GSH/GSSG, the opposite situation to that observed in the cytoplasm. It was
therefore surprising to find secreted glutathionylated proteins, and it may be that the glutathio-
nylation takes place in the cytoplasm before the release of the protein. On the other hand, it
Fig 5. PRDX1 is not released associated with influenza virions. A549 cells were infected (+) or mock infected (-) as described in the Methods.
Supernatants were blocked with 40 mMNEM, concentrated and the virions immunoprecipitated with anti-influenza antibody. Immunoprecipitated samples
and supernatants left after immunoprecipitation were run under non-reducing (A) or reducing conditions (B) and analyzed byWestern blot with anti-PRDX1
(A) or anti-HA (B) antibody.
doi:10.1371/journal.pone.0127086.g005
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should be noted that at least one plasma protein, transthyretin, although it is predominantly
present in cysteinylated form, could also be found, although to a lesser extent, as a glutathiony-
lated species [44].
Protein databases usually identify proteins as “secreted” based on the presence of a signal se-
quence for targeting to the Golgi [45]. Thus, proteins released via non-classical secretion are
not generally tagged as secreted proteins in the databases. In fact, none of the proteins investi-
gated in this paper (PRDX1, PRDX2, PFN1, TXN1, VIM) have a signal peptide, according to
the database UNIPROT (http://www.uniprot.org/). Interestingly, these proteins had all been
previously reported to be either present in the secretome or in circulation. We previously re-
ported that PRDX2 is secreted by macrophages in response to LPS [26]. Secretion of PRDX1
by various cell lines has also been reported [46], and both PRDX1 and 2 are increased in the
serum of diabetic patients with peripheral atherosclerotic disease [47] or in the secretome of
cancer cells [48]. Release of TXN1 by activated macrophages has also been described [49] and
TXN1 levels are elevated in HIV patients [50]. A previous report had also shown that VIM is
secreted by activated macrophages [51].
We were able to formally demonstrate the glutathionylation of PRDX1 and TXN1 by immu-
noprecipitation, in addition to that already reported for PRDX2 [26]. We were however unable
Fig 6. LPS-induced protein release is down-regulated by DEX. Experiments were performed as described in the legend to Fig 2 except that, when
indicated, 10 μMDEX was present during the 24-h culture. A. Supernatants were run under non-reducing conditions after blockade with NEM. Data for the
densitometric analysis are expressed as arbitrary units and are the mean ±SE (n = 4). * P<0.05 vs. control, § P<0.05 vs. LPS alone by Student’s t-test for
paired data. B. TNF-α levels as measured by ELISA. Data are mean ± SE from three independent samples. *, P<0.01 vs. LPS alone by Student’s t-test.
doi:10.1371/journal.pone.0127086.g006
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to obtain such evidence for secreted PFN1 and VIM, due to the low quality of the Western blot
obtained with the antibodies available. This may be due to the fact that low levels of secreted
proteins are present in the macrophage secretome. It should be noted, however, that these pro-
teins were previously reported to be susceptible to glutathionylation, even if those results were
obtained with intracellular, not secreted, proteins [23].
Another important observation was that PRDX1 is secreted mainly as a disulfide-linked
dimer, as we previously observed for PRDX2 [26], while we have no evidence of dimer forma-
tion with any of the other proteins investigated. Of note, despite in vitro studies indicating that
TXN1 can form disulfide-linked homodimers over several days [52], this has never been dem-
onstrated to occur in vivo, and our data confirm that this does not happen, at least in our cell
culture system.
A note of caution is advised in interpretation of the Western blot data obtained using anti-
VIM antibodies. The data confirm the presence of the protein intracellularly and its secretion
in response to LPS, but the apparent molecular weight does not correspond to the accepted
value for VIM. Although we previously found VIM among the proteins undergoing
Fig 7. LPS-induced protein release is down-regulated by thiol compounds. Cells were pre-treated with 10 mMGSH-C4 or NAC for 2 h, washed and
then LPS was added for 24 h. A. Supernatants were run under non-reducing conditions after blockade with NEM. Data for the densitometric analysis are
expressed as arbitrary units and are the mean ± SE (n = 4). * P<0.05 vs. control, § P<0.05 vs. LPS alone by Student’s t-test for paired data. B. TNF-α levels
as measured by ELISA. Data are mean ± SE from three independent samples.
doi:10.1371/journal.pone.0127086.g007
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glutathionylation [23] and others have reported that VIM is susceptible to cleavage by caspases
[53], we believe that further experiments are needed to confirm its presence in the supernatant
in our experimental conditions.
Dexamethasone, a classical anti-inflammatory agent which inhibits LPS-induced release of
TNF in our experimental model, also inhibits the LPS-induced release of PRDX1, PRDX2,
TXN1 and PFN1 (Fig 6) indicating that their release parallels that of other inflammatory medi-
ators. The pattern of regulation was different with antioxidant thiols, GSH-C4 and NAC. As
shown in Fig 7, these molecules, particularly GSH-C4, inhibited the LPS-induced release of
PRDX1, PRDX2, PFN1 and, to a lesser extent, TXN1, but did not affect that of TNF-α. This
finding supports the idea that the release of these proteins is more susceptible to redox regula-
tion than that of TNF-α.
Another major difference with respect to inflammatory cytokines, such as TNF-α, is that all
the proteins identified are normally present in the cell and their expression is not induced by
LPS. This is very similar to the behaviour of HMGB1, a danger signal that is released in re-
sponse to LPS from a preformed pool [4]. Obviously, all the proteins we identified will also be
released as a consequence of cell death by necrosis, along with any other cytoplasmic proteins.
Release of proteins by necrosis and subsequent recognition of these proteins as danger signals
that induce an inflammatory response has been described for HMGB1 [54], ATP [55], and var-
ious PRDXs [56].
However, the release of these proteins reported here is not simply secondary to cell necrosis.
First of all, LPS-treated cells are not dead and actively respond by inducing TNF-α production,
as shown here. Furthermore, cell viability as assessed by CellTiter-Blue, an assay that would be
able to detect a 5% toxicity, was not significantly affected by LPS (viability 99.6%). These find-
ings were confirmed using a different assay of cell viability (CellTitre Glo). More convincingly,
by loading different amounts of a cell lysate we could extrapolate that, based on PRDXWestern
blots, only the lysis of more than 40% of the cells would account for the levels of PRDX1
secreted.
These findings open the question of the biological relevance of the secretion of these pro-
teins. Of the proteins investigated, we focused our attention on redoxins (PRDX1, PRDX2,
TXN1) because they are already known to have inflammatory or cytokine-like activities. In
particular, PRDX1 and PRDX2 can stimulate production of inflammatory cytokines [26, 56,
57] and activate NK cells [58]. TXN1 has also cytokine-like properties, including upregulation
of IL-2 receptor [59] and chemotactic activity [60]. Furthermore, as PRDXs are thioredoxin
peroxidases, these proteins belong to the same metabolic pathway, and we speculate that they
could carry out peroxidatic reactions and thiol-disulfide exchange in the extracellular milieu,
particularly in inflammatory conditions when hydrogen peroxide may also be present [26].
We also report that influenza virus-infected epithelial cells release redoxins. It is known that
viruses, including influenza, can induce oxidative stress and this can be important in activating
intracellular signalling pathways involved in viral replication as well as cytokine production
[61–64]. An exaggerated inflammatory response to some highly virulent strains, due to mecha-
nisms yet to be defined, is thought to be responsible for higher mortality associated with these
infections [65], and it may well be that factors such as oxidative stress could play an important
pathogenic role. It is possible that redoxins are associated with the viral particles. Glutaredoxin
has been detected within HIV-1, even if its very low levels led the authors to speculate a passive
incorporation by the virus [66]. Our data on immunoprecipitated viral particles suggest that
this is not the case, at least for PRDX1, although we cannot definitely rule out that a small
amount of the protein could be passively incorporated into virions, or that this could happen
for other proteins.
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Further studies will be required to determine the possible mechanisms by which these pro-
teins are secreted. As discussed above, none of these proteins have signal peptides and so must
be secreted via a non-classical route. We recently showed that the secretion of two of the pro-
teins studied here, PRDX1 and 2, was dependent on oxidation of cysteine residues to form dis-
ulphide-linked homodimers [35]. Although none of the other proteins described here (TXN1,
PFN1 and VIM) were detected as dimers in our experimental conditions, it is still possible that
other forms of cysteine oxidation (for example glutathionylation) may be implicated in their
release.
In conclusion, using redox proteomics we have identified a number of proteins released in
response to LPS and influenza virus. Further studies will be required to investigate the possible
role of the proteins identified here, as well as to validate all the 46 proteins identified by redox
proteomics analysis. While some may have immunoregulatory effects, in a manner similar to
that of the PRDXs and TXN1, other proteins may be useful as biomarkers of oxidative stress as-
sociated with inflammation. Identifying proteins secreted under specific oxidative conditions
may in fact provide more information than that obtained by measuring the absolute concentra-
tion of a protein, as it has recently been shown for pentraxin 3, that can also be oxidized to
form disulfide-linked oligomers that represent a better biomarker for sepsis [67]. Development
of new techniques to detect specific oxidation forms of the proteins described here is currently
under way and these assays may provide novel biomarkers of diseases associated with oxidative
stress.
MATERIALS ANDMETHODS
Reagents
Lipopolysaccharide (LPS) from E. coli 055:B5 was from Sigma. Influenza A/Puerto Rico/8/34
H1N1 virus (PR8) was grown in the allantoic cavities of 10-day-old embryonated chicken eggs
and harvested after 48h at 37°C. Glutathione ethyl ester, biotin amide (BioGEE, Invitrogen)
was dissolved in DMSO and then diluted to a final concentration of 200 μM in cell-culture me-
dium. Dexamethasone 21-phosphate disodium salt, N-acetyl-L-cysteine, and N-ethylmalei-
mide were from Sigma-Aldrich. GSH-C4 was from Pepnome Limited, Hong Kong, China.
Cell cultures
RAW264.7 mouse macrophages were cultured in RPMI 1640 medium (Sigma Aldrich) with
10% FBS (Invitrogen). Treatment with BioGEE and/or LPS was performed in serum-free
OPTI-MEM I medium (Invitrogen). Cells were plated in 6-well plates (1 x 106 in 3 ml of RPMI
with 10% FBS). One day later, medium was changed to 1 ml of OPTI-MEM. Where indicated,
BioGEE was added to a final concentration of 200 μM 1 h before LPS stimulation (100 ng/ml,
for 24h). DEX was used at 10 μM for 24h. NAC and GSH-C4 were used at 10 mM for 2h and
removed by washing with PBS before performing LPS stimulation as describe above. Superna-
tants were collected and N-ethylmaleimide (NEM) added to a final concentration of 40 mM
(from a 1M stock solution) to avoid thiol-disulfide exchange. Cells were lysed with sample buff-
er containing 40 mMNEM. Cell viability was measured in 96-wells microtiter plates using
CellTiter-Blue assay (Promega). A549 human lung epithelial cells were cultured in DMEMme-
dium (Sigma Aldrich) with 10% FBS (Invitrogen) and infected with PR8 at a multiplicity of in-
fection (MOI) of 4, incubating the cells with the virus for 1h at 37°C in serum-free medium,
washing with PBS and then adding medium with 2% FBS for 24h. Virus production was deter-
mined in cell supernatants by measuring hemagglutinin units as described previously [31].
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Cell viability assays
Cells were plated at 25,000/well in 96-well plates in RPMI + 10% FBS. After overnight culture,
the medium was replaced with serum-free OPTI-MEM I and the cells were incubated with or
without 100 ng/ml of LPS. After 24 h, cell viability was measured with CellTiter-Blue or CellTi-
ter-Glo (both from Promega), following the instructions of the manufacturer.
Mass spectrometry and data analysis
RAW264.7 cells were cultured in 6-well plates in 1.5 ml of OPTI-MEM as described above.
Two wells were pre-loaded with BioGEE and then treated with LPS as described above, the
other two wells were treated identically except that they were not pretreated with BioGEE.
Twenty-four hours after addition of LPS, the supernatants from the two wells were collected
and combined, NEM added to a final concentration of 40 mM, and concentrated to 300 μL
using 5 kDa-cutoff Vivaspin columns (GE Healthcare) at 4°C. The concentrated proteins were
then mixed with 50 μL of streptavidin-agarose (Sigma) and incubated under rotation for
30 min at 4°C. The beads were then washed with cold PBS, followed by two washes with cold
PBS containing 0.1% SDS, and then with 25 mMNH4CO3. Proteins attached to the beads were
then subjected to 2,2,2-Trifluoroethanol-enhanced trypsin digestion in situ, essentially as de-
scribed [68]. Following addition of trypsin, samples were incubated for 18 hours at 37°C, and
the digestion reaction was quenched by the addition of TFA to 0.1% prior to LC MS/MS analy-
sis as described below.
For the SDS-PAGE fractionated samples (second experiment), the resulting gel bands were
excised and subjected to trypsin in-gel digestion essentially as previously described [69]. The
supernatant from the digested samples was removed and acidified to 0.1% TFA, dried down,
and reconstituted in 0.1% TFA prior to LC-MS/MS analysis.
In both cases, for LC-MS/MS the resulting peptides were fractionated on a 250 mm x
0.075 mm reverse phase column using an Ultimate U3000 nano-LC system and a 2 hour linear
gradient from 95% solvent A (0.1% formic acid in water) and 5% B (0.1% formic acid in 95%
acetonitrile) to 50% B at a flow rate of 250 nL/min. Eluting peptides were directly analysed by
tandemMS using a LTQ Orbitrap XL hybrid FTMS (ThermoScientific) and the derived MS/
MS data searched against the ipi. MOUSE.v3.72 database (56957 entries) [70] using Sequest
version SRF v.5 as implemented in Bioworks v3.3.1, assuming carboxyamidomethylation
(Cys), deamidation (Asn) and oxidation (Met) as variable modifications and using a peptide
tolerance of 10ppm and a fragment ion tolerance of 1.0 Da. Filtering criteria used for positive
protein identifications are Xcorr values greater than 1.9 for +1 spectra, 2.2 for +2 spectra and
3.75 for +3 spectra, a delta correlation (DCn) cut-off of 0.1 and at least two unique peptides.
Western blot analysis and immunoprecipitation
Supernatants, after blocking thiols by alkylation with NEM, were centrifuged to eliminate cellu-
lar debris and analyzed by SDS-PAGE under non-reducing or reducing conditions (by addition
of 10 mM DTT), followed by Western blotting. According to the molecular weight of the pro-
tein of interest, gels with different percentage of acrylamide were used (ranging from 7.5% to
15%). Biotinylated proteins were visualized using streptavidin peroxidase (Roche) at 1:25,000
dilution. Western blot for other proteins used the following antibodies,: anti-PRDX1 (Abcam,
cat. 41906), anti-PRDX2 (prepared against human PRDX2 but cross-reacting with mouse
PRDX2, as described elsewhere [71]) at 1:1000 dilution, anti-mouseTXN1 (IMCO) at 1:2000
dilution, Anti-VIM (Sigma, cat. AV48225), at 1:500 dilution, anti-PFN1 (Sigma, cat P7624) at
1:500 dilution. Membranes were then incubated with an anti-rabbit HRP-linked secondary an-
tibody (Sigma, cat. A0545) at 1:25,000 dilution and developed using ECLWB Analysis System
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(GE Healthcare). For immunoprecipitation experiments, supernatants from BioGEE labelled,
LPS-stimulated RAW264.7 cells, blocked with NEM, were concentrated using 5 kDa Vivaspin
columns and incubated with anti-PRDX1 (Abcam, cat. 41906) or anti-TXN1 (IMCO) at
1:100 dilution at 4°C for 4h; then the immunocomplex was precipitated with protein G agarose
(Pierce) at 4°C for 18h. Agarose beads were washed three times with cold PBS and then eluted
by boiling in sample buffer for 4 minutes. Eluate was split into two aliquots, one reduced with
10 mMDTT, one left untreated and both loaded on SDS-PAGE gels (12% and 15% acrylamide
for PRDX1 and TXN1, respectively) followed by Western blot with streptavidin peroxidase as
described above. The same blots were then stripped with stripping buffer (Thermo scientific)
and reprobed with anti-PRDX1 and anti-TXN1. When indicated, densitometric analysis was
performed on the Western blots, following scanning, using GeneTools (Syngene) version
4.02.01.
To immunoprecipitate influenza viral particles, supernatants from PR8-infected A549 cells
were blocked with NEM, concentrated using 10 kDA vivaspin columns and incubated with
anti-influenza antibody (MerckMillipore, cat. AB1074) at 1:100 dilution at 4°C for 4h; then the
particles were immunoprecipitated with Protein A/G Plus-Agarose (Santa Cruz Biotechnology)
at 4°C overnight. Agarose beads were washed four times with PBS and then eluted with sample
buffer at 100°C for 4 minutes. Eluate was split into two aliquots, one run on SDS-PAGE under
non reducing conditions and analysed in Western blot with anti-PRDX1 antibody, as described
above; the other one was reduced with DTT, before electrophoresis and Western blot analysis
with anti-HA antibody (Santa Cruz Biotechnology, cat. sc-52025) at 1:1000 dilution.
ELISA for TNF-α and IL-6
Mouse TNF-α and human IL-6 were assayed by ELISA using a DuoSet kit from R&D Systems
according to the manufacturer’s instructions.
Supporting Information
S1 Fig. Glutathionylated proteins released by RAWmacrophages after stimulation with
LPS. A. Cells were preloaded with BioGEE where indicated, then stimulated with 100 ng/ml
LPS for 24h. The supernatants were reduced with 10 mM DTT for 15 min or left untreated,
then loaded on a 12% SDS-PAGE followed by Western blot with streptavidin-peroxidase. B.
RAW cells were incubated with Bio-GEE for 1 hour, the medium was then removed and cells
were washed with OPTI-MEM and replaced with fresh medium containing 100 ng/mL of LPS.
Cell supernatants were collected and NEM added to a final concentration of 50 mM. Superna-
tants were applied to a SDS-PAGE gel and probed with streptavidin peroxidase.
(TIF)
S2 Fig. Gel electrophoresis of the eluates from streptavidin beads. The supernatant from
BioGEE-preloaded, LPS-stimulated RAW264.7 cells was incubated with streptavidin agarose
and then eluted with 10 mM DTT for 30 min at room temperature and then again with 10 mM
DTT for 10 min at 100°C. The eluate was run on SDS-PAGE under reducing condition and
stained with Coomassie Blue. The three bands indicated by numbers were cut and used for
protein identification.
(TIF)
S3 Fig. Stability of PRDX2 monomer in cell culture.Human recombinant PRDX2 was ex-
pressed in E. coli with an N-terminal His-tag and purified using nickel agarose beads. Purified
PRDX2 was incubated overnight at 37°C with 5% CO2 in complete DMEM in the presence of
adherent HEK 293T cells (lanes 1–3) or in complete DMEM in the absence of cells (lanes 4–6).
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Proteins were then loaded on a 12% acrylamide gel for Western blotting with anti-
His antibody.
(TIF)
S4 Fig. Sensitivity of CellTiter Blue for detection of cell viability. Cells were plated in 96 well
plates at 25,000/well (100%) or at the indicated percentage, down to 15,000 cells/well (60%).
After overnight incubation, cells were treated with LPS 100 ng/ml (LPS) or medium alone (ctr)
and incubated for 24 hrs. Then CTB (20 μl /well) was added and fluorescence detected after 3h.
Results are the mean ± SD of quadruplicate samples.  P< 0.05 vs ctr; P< 0.001 vs ctr by
Student’s t-test.
(TIF)
S5 Fig. Effect of 10 mMNAC on PRDX2 release by LPS-stimulated RAW264.7 cells. Experi-
ment was carried out as in the legend to Fig 2, except that different concentrations of LPS were
used (0–100 ng/ml), with or without 10 mMNAC present during the entire 24-h culture.
(TIF)
S1 Table. Proteins identified in the 3 bands excised from the gel shown in S1 Fig.
(XLSX)
S2 Table. Proteins identified in the samples prepared without or with BioGEE, following
affinity purification on streptavidin beads.
(XLSX)
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